Wolbachia-carrying Ae.aegypti mosquitoes
PreclinicalBiologic
Wolbachia-carrying Ae.aegypti mosquitoes is one of 56 biologic programs targeting Viral Disease. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
55
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
56 competitors in Viral Disease
#DrugCompanyPhaseTrials
1Videx
Bristol-Myers SquibbApproved
Selzentry
GSKApproved
Emtriva
GileadApproved
Vemlidy
GileadApproved
Hepsera
GileadApproved
Tivicay
GSKApproved
Vistide
GileadApproved
Xofluza
RocheApproved
Incivek
Vertex PharmaceuticalsApproved
Famvir
NovartisApproved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversidad de Antioquia